1. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. Issue 5 (May 2020) Authors: Pfisterer, Jacobus; Shannon, Catherine M; Baumann, Klaus; Rau, Joern; Harter, Philipp; Joly, Florence; Sehouli, Jalid; Canzler, Ulrich; Schmalfeldt, Barbara; Dean, Andrew P; Hein, Alexander; Zeimet, Alain G; Hanker, Lars C; Petit, Thierry; Marmé, Frederik; El-Balat, Ahmed; Glasspool, Rosalind; de... Journal: Lancet oncology Issue: Volume 21:Issue 5(2020) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis. Issue 6 (30th January 2022) Authors: Chazan, Grace; Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun; Kwan, Edmond M; Spain, Lavinia; Gunjur, Ashray; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Gibbs, Peter; Tran, Ben Journal: Asia-Pacific journal of clinical oncology Issue: Volume 18:Issue 6(2022) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Catalyst-free C–N bond formation under biocompatible reaction conditions. Issue 8 (6th April 2022) Authors: Goh, Jeffrey; Ong, Seng Kheong; Tan, Yan Sheng; Loh, Teck-Peng Journal: Green chemistry Issue: Volume 24:Issue 8(2022) Page Start: 3321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures. Issue 4 (10th November 2016) Authors: Pittman, Kenneth; Antill, Yoland C; Goldrick, Amanda; Goh, Jeffrey; de Boer, Richard H Journal: Asia-Pacific journal of clinical oncology Issue: Volume 13:Issue 4(2017) Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer. Issue 4 (22nd September 2021) Authors: Cohen, Paul A; Webb, Penelope M; King, Madeleine; Obermair, Andreas; Gebski, Val; Butow, Phyllis; Morton, Rachael; Lawson, Wanda; Yates, Patsy; Campbell, Rachel; Meniawy, Tarek; McMullen, Michelle; Dean, Andrew; Goh, Jeffrey; McNally, Orla; Mileshkin, Linda; Beale, Philip; Beach, Rhonda; Hill, Ja... Journal: International journal of gynecological cancer Issue: Volume 32:Issue 4(2022) Page Start: 560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. High‐dose chemotherapy for relapsed germ cell tumours: outcomes in low‐volume specialized centres. (31st March 2022) Authors: Connolly, Elizabeth A.; Weickhardt, Andrew; Grimison, Peter; Asher, Rebecca; Heller, Gillian Z.; Lewin, Jeremy; Liow, Elizabeth; Toner, Guy; Tung, Iris L.Y.; Tran, Ben; Hill, Sean; Walpole, Euan; McKenzie, Jane; Kuchel, Anna; Goh, Jeffrey; Forgeson, Garry; Tan, Alvin; Joshi, Abhishek; Wickham, Al... Journal: BJU international Issue: Volume 130(2022)Supplement 1 Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Nutrition risk screening and implications for patients with gynaecological cancers undergoing pelvic radiotherapy and/or other treatment modalities: A retrospective observational study. Issue 2 (2nd December 2021) Authors: Croisier, Emilie; Morrissy, Alana; Brown, Teresa; Grigg, Alice; Chan, Philip; Goh, Jeffrey; Bauer, Judy Journal: Nutrition & dietetics Issue: Volume 79:Issue 2(2022) Page Start: 217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. O003/#557 Overall survival results from ARIEL3: a phase 3 randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma. (4th December 2022) Authors: Coleman, Robert L; Oza, Amit; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne; Clamp, Andrew; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert; Gancedo, Margarita Amenedo; Fong, Peter; Goh, Jeffrey; O'Malley, David; Goble, Sandra; Malon... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Practical considerations for clinicians for transitioning patients on maintenance therapy with olaparib capsules to the tablet formulation of olaparib. Issue 6 (26th November 2018) Authors: Friedlander, Michael; Shannon, Catherine; Goh, Jeffrey; Scott, Clare; Mileshkin, Linda Journal: Asia-Pacific journal of clinical oncology Issue: Volume 14:Issue 6(2018) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Practical guidance on the use of olaparib capsules as maintenance therapy for women with BRCA mutations and platinum‐sensitive recurrent ovarian cancer. Issue 4 (December 2016) Authors: Friedlander, Michael; Banerjee, Susana; Mileshkin, Linda; Scott, Clare; Shannon, Catherine; Goh, Jeffrey Journal: Asia-Pacific journal of clinical oncology Issue: Volume 12:Issue 4(2016) Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗